HeartBeam, Inc. (BEAT) stock
BEATNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as BEATW
$0.55+0.01 (+2.06%)
Close on Oct 30, 2026Market cap $659.29KP/E –Yield –
HeartBeam free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
HeartBeam's free cash flow for the twelve months ending Jun 30, 2026 was -$14.01M. For fiscal 2025 it was -$14.59M.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$14.59M | – |
| FY2024 | Dec 31, 2024 | -$14.67M | – |
| FY2023 | Dec 31, 2023 | -$12.35M | – |
| FY2022 | Dec 31, 2022 | -$9.95M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$3.59M | – |
| Q1 FY2026 | Mar 31, 2026 | -$3.86M | – |
| Q4 FY2025 | Dec 31, 2025 | -$3.32M | – |
| Q3 FY2025 | Sep 30, 2025 | -$3.24M | – |
| Q2 FY2025 | Jun 30, 2025 | -$3.55M | – |
| Q1 FY2025 | Mar 31, 2025 | -$4.48M | – |
| Q4 FY2024 | Dec 31, 2024 | -$4.15M | – |
| Q3 FY2024 | Sep 30, 2024 | -$3.41M | – |
| Q2 FY2024 | Jun 30, 2024 | -$3.56M | – |
| Q1 FY2024 | Mar 31, 2024 | -$3.55M | – |
| Q4 FY2023 | Dec 31, 2023 | -$2.97M | – |
| Q3 FY2023 | Sep 30, 2023 | -$2.24M | – |
| Q2 FY2023 | Jun 30, 2023 | -$4.02M | – |
| Q1 FY2023 | Mar 31, 2023 | -$3.11M | – |
| Q4 FY2022 | Dec 31, 2022 | -$2.96M | – |